Focal liver lesions (FLLs) comprise a diverse range of benign and malignant conditions. Although advanced imaging improves lesion characterization, histopathologic assessment remains the diagnostic gold standard for indeterminate lesions. Data on the histopathologic spectrum of FLLs and the diagnostic utility of ultrasound-guided percutaneous liver biopsy (US-PLB) are limited in sub-Saharan Africa (SSA). This single-center study aimed to describe histopathologic diagnoses obtained via US-PLB for FLLs and to identify clinicopathologic factors associated with hepatocellular carcinoma (HCC).
The investigators conducted a retrospective observational review of adult patients (≥18 years) who underwent US-PLB for focal liver lesions at Adera Medical and Surgical Center between January 2021 and December 2024. Exclusion criteria were indeterminate pathology results, incomplete records, biopsies performed for diffuse liver disease, and lesions classified as LI-RADS 1, 2, or 5. Demographic, clinical, laboratory, imaging, histopathologic, and outcome data were extracted from medical records. Descriptive statistics summarized patient characteristics and histopathologic diagnoses. Logistic regression analyses were used to identify factors associated with HCC.
All included cases underwent ultrasound-guided percutaneous liver biopsy. The authors report no major biopsy-related complications among the 119 patients analyzed, indicating a favorable immediate safety profile for US-PLB performed in this tertiary referral setting.
A total of 119 patients met inclusion criteria. The median age was 56 years (interquartile range 45–65), and 59.7% of patients were male. The study population included patients referred for evaluation of focal liver lesions deemed indeterminate on imaging and selected for histopathologic diagnosis by US-PLB.
The distribution of final histopathologic diagnoses was:
These results indicate that primary liver cancer (HCC) was the predominant finding among biopsied focal lesions in this cohort.
Tests for viral hepatitis identified hepatitis B virus (HBV) infection in 14.3% of patients and hepatitis C virus (HCV) infection in 12.4% of patients. The study assessed the association between these viral infections and the likelihood of histopathologic diagnosis of HCC.
On multivariate logistic regression, three factors were independently associated with a histopathologic diagnosis of HCC:
These associations indicate substantially higher odds of HCC among patients with chronic viral hepatitis and with increasing lesion size in this cohort.
In this single-center SSA experience, ultrasound-guided percutaneous liver biopsy had a favorable safety record and provided definitive histopathologic diagnoses in patients with indeterminate focal liver lesions. HCC accounted for the largest proportion of diagnoses (42.9%), reflecting a significant burden of primary liver cancer in this population. Chronic viral hepatitis (HBV and HCV) and larger tumor size were independently associated with HCC, supporting the ongoing need for viral hepatitis prevention, surveillance, and early detection strategies in the region.
The authors emphasize the continued role of US-PLB for diagnostic evaluation when imaging is indeterminate, and they highlight public health priorities to reduce HCC incidence via viral hepatitis control.
The study was approved by the Institutional Review Board of Adera Medical and Surgical Center and conducted according to the Declaration of Helsinki. Written informed consent was obtained from patients before biopsy; the IRB waived additional consent for retrospective chart review. Patient identifiers were removed prior to analysis.
As this report is a medRxiv preprint, the findings have not undergone peer review. The source text does not provide full details on certain methodological elements (for example, exact biopsy technique, needle type, number of passes, or long-term follow-up data), and those specifics were not reported in the source. Readers should interpret the results in light of the single-center, retrospective design and the preprint status.